Cerebral-palsy trials concentrate in Asia and Latin America, with fewer in Europe or North America. Asian centres cost less but with lighter oversight; US, Canadian and European trials follow stricter FDA/EMA standards and better adverse-event reporting. Registered trials in regulated jurisdictions offer the best safety profile, though fewer exist.
Indicative European costs are roughly €4,000–€7,500 per course. Paediatric infusions add safety monitoring and often use multiple small doses over weeks. Some protocols bundle intensive rehabilitation, adding further cost. For context, physiotherapy, botulinum toxin and orthopaedic surgery are established, often insurance-covered interventions — the stem-cell figure is indicative and unproven.
Am I a candidate? → · Cerebral Palsy: full overview → · Cerebral Palsy cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment